Corporate Governance: Japan's Inconvenient Truth

Nov. 27, 2018 08:00 - 09:30


  • Online bookings are closed for this event.

Breakfast session led by the best - and arguably most energetic - CFO in Japan's healthcare sector

Corporate governance - the system by which companies are directed and controlled - has been cited as a key pillar of Prime Minister Abe's 'Abenomics' programme. Since changes in 2015 to the Corporate Governance Code, reforms in Japan have been progressing slowly but surely.

The aim of the reforms is to improve transparency and re-write relationships between businesses, investors and society. Long-term, these changes are designed to boost competitiveness. Companies that embrace the positive spirit - and not just the letter - of good governance may be able to achieve more sustainable growth.

Given Japan's current demographics, the reforms are also key to the attractiveness of Japanese stocks. Domestic companies are urged to rediscover their ambition, seek opportunities to expand at home and abroad, aim for higher productivity and equity returns, and pass on the benefits to all stakeholders -  and crucially, to shareholders.

More important milestones are up ahead: unwinding cross shareholdings, the broader adoption of compensation and nomination committees, and having greater diversity on boards. These are all steps necessary for creating a better business environment - and achieving better commercial results for Japan Inc.

With the end of another year in sight - how is the nation doing in its bid to realise better governance, transparency and financial returns? How seriously are captains of industry taking Corporate Governance towards the end of 2018? Can the country unlock its untapped corporate value before it's too late?

Join us for a breakfast session on September 27 with the CFO of Eisai Co., Ltd, Ryohei Yanagi who will share with BCCJ members up-to-date insights on corporate governance and value creation in Japan, and reveal some inconvenient truths along the way.


About the speaker

Ryohei Yanagi is Chief Financial Officer of Eisai Co., Ltd., one of the largest pharmaceutical companies in Japan. He is also Visiting Professor at Toyo University and Visiting Lecturer at Waseda University Graduate School of Accountancy, where he teaches corporate governance, corporate finance and investor relations. He earned his Ph.D. from Kyoto University. During the last 15 years, Dr. Yanagi has conducted approximately 3,000 meetings in aggregate with global investors (about 200 meetings per annum) throughout his career with UBS as Executive Director and at Eisai as CFO. He was selected as the Best CFO in Japan’s healthcare sector in 2016 and 2017 by the Institutional Investor magazine.


Corporate Governance and Value Creation in Japan: Prescriptions for Boosting ROE HERE



Event Coupons: Members can use free seat coupons to attend this event. *** (Log in before booking your seat) *

Meal: Plated breakfast included in ticket price

Cancellation policy: Paid reservations by Nov 16 Fri 12:00 after which there can be no refunds on cancellations. No-shows will be charged.  We can not accept cash at the door.

Dietary requirements: Please let us know at the time of booking if you have any dietary requests.

参加費無料クーポン: 2018年度年会費をお支払いいただいた企業会員の方は参加費無料のクーポンを使用できます。必ずHome page (このウェッブサイトの1ページ目)でLOGINしてからお申し込みくださるようお願いいたします。 イベント後にクーポン使用のご希望をいただいてもお断りする場合がございます。必ずイベント前にご連絡をお願いいたします。

お申し込みとキャンセル・お支払い: お申し込みと同時にご送金をお願いいたします。締切り(11月16日午後12時)後のキャンセルはお受けできません。 お名前の変更は出来ます。 



お食事:お食事に制限のある方 (ベジタリアン・アレルギーなど)は 必ずお申し込みと同時にお知らせくださるようお願いいたします。 締切日以降・当日の変更はお受けできません。


Venue Information

Shangri-La Hotel Tokyo
27F Pavilion Room

Venue link
Access Map

Access Map

Payment Options:

  • Paypal
  • Bank transfer

Member Cost: ¥6,500

Non-Members Cost: ¥8,500